( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57



Dr. Sunita Singh, Dr. Vikas, Dr. Yashika Bhatia*, Dr. Ishwar Singh, and Dr. Rajeev Sen


Objective: Glial tumors as a group constitute one of the important tumors of brain both in India and in the world. The present study was done with the aim to study immunohistochemical expression of nestin in glial tumors and to evaluate expression of nestin in different grades of Gliomas according to WHO grading. Material and Methods: A total of 40 cases of glial tumors were included in the study. Glial tumors were graded histomorphologically as Pilocytic astrocytoma, Fibrillar Astrocytoma (Grade-II), Anaplastic Astrocytoma (Grade-III), Glioblastoma, Oligodendroglioma (Grade-III) and Oligoastrocytoma (Grade-II). Nestin expression was assessed and correlated with histopathological grade (WHO classification) of glial tumors. Furthermore, immunochemistry for GFAP, S-100 and VEGF was applied and correlation between nestin expression and GFAP, S-100 and VEGF was studied. Results: Out of 40 cases, most of the cases were Glioblastoma Multiforme; WHO grade IV(42.5%) followed by astrocytoma; WHO grade II (22.5%) and anaplastic astrocytoma; who grade III(12.5%). Nestin expression was assessed and correlated with histopathological grade (WHO classification) of glial tumors. Nestin immunoexpression was present in 35 cases (89.5%) out of 40 cases. Out of 40 cases of glial tumors, GBM constitute 17 cases. Out of which 16 cases showed maximum nestin grading (3+). In lower grade gliomas (WHO grade I & II) immunoexpression of nestin was weak. Statistically significant correlation was noted in the immunoexpression of VEGF and Nestin, (p value 0.008). Conclusion: There is increase in immunoexpression of nestin with increase in grade of malignancy from WHO grade I to IV. Nestin expression may be a potential indicator of biological aggressiveness of the tumors and may be considered as marker of tumor burden and recurrence in human gliomas.

Keywords: glial tumors, astrocytoma, oligodendroglioma and nestin.

[Full Text Article] [Download Certificate]


  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44



  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 April 2024 Issue has been Published, Kindly check it on


    APRIL 2024 issue has been successfully launched on APRIL 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia